Safety assessment of probiotic Lactiplantibacillus plantarum MCC5231 and its persistence in gastrointestinal tract
Microbial Pathogenesis · 2024
DOI: 10.1016/j.micpath.2024.106824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2024. Verfasst von Aditi Goel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Fermentation Technology Department, CSIR-Central Food Technological Research Institute, Mysuru, 570020, Karnataka, India. Electronic…. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Tract, Biofilms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microbiology and Fermentation Technology Department, CSIR-Central Food Technological Research Institute, Mysuru, 570020, Karnataka, India. Electronic address: adits225@gmail.com.
- Microbiology and Fermentation Technology Department, CSIR-Central Food Technological Research Institute, Mysuru, 570020, Karnataka, India. Electronic address: prakashalami@cftri.res.in.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Goel, A., & Halami, P. M. (2024). Safety assessment of probiotic Lactiplantibacillus plantarum MCC5231 and its persistence in gastrointestinal tract. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2024.106824
Vancouver
Goel A, Halami PM. Safety assessment of probiotic Lactiplantibacillus plantarum MCC5231 and its persistence in gastrointestinal tract. Microbial Pathogenesis. 2024. doi:10.1016/j.micpath.2024.106824
BibTeX
@article{Goel2024,
author = {Goel, Aditi and Halami, Prakash M},
title = {Safety assessment of probiotic Lactiplantibacillus plantarum MCC5231 and its persistence in gastrointestinal tract},
journal = {Microbial Pathogenesis},
year = {2024},
doi = {10.1016/j.micpath.2024.106824}
}
EUVIMED